Attached files

file filename
EX-5.1 - EX-5.1 - HCA Healthcare, Inc.d731934dex51.htm
EX-1.1 - EX-1.1 - HCA Healthcare, Inc.d731934dex11.htm

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): May 23, 2014 (May 19, 2014)

 

 

HCA HOLDINGS, INC.

(Exact Name of Registrant as Specified in its Charter)

 

 

 

Delaware   001-11239   27-3865930

(State or Other Jurisdiction

of Incorporation)

  (Commission File Number)  

(I.R.S. Employer

Identification No.)

 

One Park Plaza, Nashville,

Tennessee

  37203
  (Address of Principal Executive Offices)   (Zip Code)

Registrant’s telephone number, including area code: (615) 344-9551

Not Applicable

(Former Name or Former Address, if Changed Since Last Report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 


Item 1.01. Entry into a Material Definitive Agreement.

Underwriting Agreement

On May 19, 2014, HCA Holdings, Inc. (the “Company”) entered into an Underwriting Agreement (the “Underwriting Agreement”) by and among the Company, Citigroup Global Markets Inc. (the “Underwriter”) and the selling shareholders listed on Schedule A thereto (the “Selling Shareholders”), relating to the underwritten offering of 15,000,000 shares (the “Shares”) of the Company’s common stock, par value $0.01 per share, pursuant to the Company’s Registration Statement on Form S-3 (File No. 333-175791), filed on December 10, 2012, as supplemented by the prospectus supplement dated May 19, 2014. All of the Shares are being sold by the Selling Shareholders. Pursuant to the Underwriting Agreement, the Underwriter purchased the Shares at a price of $51.53 per share in a transaction that was completed on May 23, 2014.

The description of the Underwriting Agreement is qualified in its entirety by the terms of such agreement, which is incorporated herein by reference and attached to this report as Exhibit 1.1.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits

 

Exhibit No.

  

Description

1.1

   Underwriting Agreement, dated as of May 19, 2014, among HCA Holdings, Inc., the Selling Shareholders named on Schedule A thereto, and Citigroup Global Markets Inc., as Underwriter

5.1

   Opinion of Simpson Thacher & Bartlett LLP

23.1

   Consent of Simpson Thacher & Bartlett LLP (included in Exhibit 5.1)

 

2


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

HCA HOLDINGS, INC.

(Registrant)

By:   /s/ William B. Rutherford                        
  William B. Rutherford
 

Executive Vice President and Chief

Financial Officer

Date: May 23, 2014

 

3


INDEX TO EXHIBITS

 

Exhibit No.

  

Description

1.1

   Underwriting Agreement, dated as of May 19, 2014, among HCA Holdings, Inc., the Selling Shareholders named on Schedule A thereto, and Citigroup Global Markets Inc., as Underwriter

5.1

   Opinion of Simpson Thacher & Bartlett LLP

23.1

   Consent of Simpson Thacher & Bartlett LLP (included in Exhibit 5.1)

 

4